RxDoctor Payments Data

Peter Neglen

Vascular Surgery · Flowood, MSNPI 1518990720

Payments from drug & device makers

What this record shows

This record is dominated by ownership interests: $363,972 of the $598,582 with a category attached, or 60.8%. Boston Scientific accounts for 95.9% of it on its own, with 1 other manufacturer making up the rest. Among vascular surgery clinicians in MS with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$598,582in general payments, 2019–2025

Across 9 payments — averaging $66,509 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$574K
  • Veniti, Inc.$25K

What the payments were for

  • Royalty or licence$234,61139%
  • Ownership interest$363,97261%

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Boston Scientific8$573,813
Veniti, Inc.1$24,769

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$598,582 in reported general payments places this provider in the 95th percentile of 39 vascular surgery providers in Mississippi.

See all vascular surgery providers in Mississippi

Other vascular surgery in Flowood

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →